Elicio Therapeutics, Inc.
Pharmaceutical company · Boston, Massachusetts, United States · Nasdaq: ELTX
Elicio Therapeutics, Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2011. Its shares trade on Nasdaq under the ticker ELTX. It has reported private securities offerings to the US SEC, most recently $6 million sold in a notice filed in 2024.
What does Elicio Therapeutics do?
Private fundraising reported to the SEC
21 Form D notices; the most recent reported $6 million sold (2024).
Frequently asked questions about Elicio Therapeutics
Where is Elicio Therapeutics headquartered?
Elicio Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.
What does Elicio Therapeutics do?
Elicio Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Elicio Therapeutics a public company?
Yes. Elicio Therapeutics, Inc. trades on Nasdaq under the ticker ELTX.
When was Elicio Therapeutics founded?
The earliest incorporation on record for Elicio Therapeutics, Inc. is in 2011, according to public company registers.
Similar companies
- Transcode Therapeutics, Inc.Boston, Massachusetts, United States
- Akouos, Inc.Boston, Massachusetts, United States
- Astria Therapeutics, Inc.Boston, Massachusetts, United States
- Albireo Pharma, Inc.Boston, Massachusetts, United States
- Atea Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Rhythm Pharmaceuticals, Inc.Boston, Massachusetts, United States
- Tango Therapeutics, Inc.Boston, Massachusetts, United States
- Paratek Pharmaceuticals, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.